The cancer therapeutics market size is expected to reach US$ 5,31,538.02 million by 2031 from US$ 2,30,423.56 million in 2024. The market is estimated to record a CAGR of 12.8% from 2025 to 2031.

 

Executive Summary and Global Market Analysis

The global cancer therapeutics market is experiencing consistent growth, a trend propelled by the rising incidence of breast and lung cancers and substantial investments in oncology research and development. Cancer therapeutics include a diverse array of treatments—such as chemotherapy, radiation therapy, immunotherapy, and targeted and hormone therapies—all designed to combat or cure cancer. Their main objective is to eliminate or control cancerous cells, alleviate symptoms, and improve a patient’s quality of life and survival. Treatment protocols often involve a combination of multiple therapies, which are meticulously personalized to the specific type and stage of cancer and the patient’s overall health.

 

Cancer Therapeutics Market Segmentation Analysis

The cancer therapeutics market is segmented across three crucial categories: therapy type, indication, and distribution channel. By therapy type, the market is categorized into chemotherapy, targeted therapy, radiation therapy, hormone therapy, and other approaches. In 2024, chemotherapy secured the largest market share. In terms of indications, the market addresses blood cancer, lung cancer, breast cancer, colorectal cancer, and other specific diagnoses. Lung cancer represented the largest share of the market in 2024. Finally, by distribution channel, the market segments are hospital pharmacies, retail pharmacies, and online stores. Hospital pharmacies maintained the largest market share in 2024.

 

Cancer Therapeutics Market Drivers and Opportunities

The immense global burden of cancer serves as a primary market driver. The World Health Organization reports that cancer is responsible for approximately one in six deaths globally. With an estimated 20 million new cancer diagnoses in 2022, this figure is projected to surge by 77% by 2050, which will significantly strain healthcare systems worldwide. The American Cancer Society notes that 5–10% of all cancers are inherited. Mutations in hereditary cancer susceptibility genes like BRCA1 and BRCA2 significantly increase the risk of developing various cancers, including breast, ovarian, and prostate. Globally, breast cancer is recognized as the most prevalent cancer among women, with its incidence continuously rising due to factors like environmental exposure, genetic susceptibility, and evolving lifestyle choices.

Download our Sample PDF Report

@ https://www.businessmarketinsights.com/sample/BMIRE00031299

 

Cancer Therapeutics Market Size and Share Analysis

Based on therapy type, the cancer therapeutics market is segmented into chemotherapy, targeted therapy, radiation therapy, hormone therapy, and other types. The chemotherapy segment held the dominant market position in 2024. Chemotherapy agents, through their cytotoxic action, effectively halt or slow the proliferation of cancer cells. These drugs are systemically delivered via the bloodstream, targeting and disrupting cancer cell growth throughout the body. The National Institutes of Health estimates that approximately 650,000 cancer patients in the US undergo chemotherapy treatment annually. Concerning indications, the lung cancer segment commanded the largest share of the market in 2024.

 

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications